AR and prostate cancer: Because normal prostate tissues rely on androgen and its receptor, androgen receptor (AR), for development and maintenance of homeostasis, targeting the AR pathway via androgen deprivation therapy (ADT) constituted a viable mechanism that was generally utilized for treatment of prostate cancer.